Brief: Sanofi: Subcutaneous Sarclisa Escena Approved In US
BRIEF-Sanofi: Subcutaneous Sarclisa Escena Approved In US July 10 (Reuters) - Sanofi SA SASY.PA:
SANOFI'S SUBCUTANEOUS SARCLISA ESCENA APPROVED IN US AS FIRST ANTICANCER TREATMENT ADMINISTERED VIA ON-BODY INJECTOR
FDA APPROVES SUBCUTANEOUS SARCLISA ESCENA FOR MULTIPLE MYELOMA
Source text: ID:nGNE53glWs
Further company coverage: SASY.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Sanofi SA
See all newsEdenTree fund manager Hiorns has bought up French stocks despite civil unrest (updated)
Early US flu season, current strain may signal risk for younger people; doctors urge shots
Brief: Sanofi Starts Work On Insulin Facility In Germany
RCS - Accession Theraptcs. - Accession Therapeutics: Board appointments
Europe Research Roundup: AJ Bell, CMC Markets, Nestle